Latest News about BIIB
Recent news which mentions BIIB
NeuroSense's (NASDAQ: NRSN) ALS Drug Candidate Shows Promise In Recent Phase 2b Trial; More Milestones To Come In 2024
January 29, 2024
From Benzinga
From Benzinga
Slow Market Penetration For Biogen's Another Alzheimer's Drug: UBS Highlights Risks, Forecasts
January 24, 2024
From Benzinga
Critical Insights From Biogen Analyst Ratings: What You Need To Know
January 24, 2024
Tickers
BIIB
From Benzinga
Highlights From the 2024 JPMorgan Health Care Conference
January 22, 2024
From Motley Fool
From Motley Fool
Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns
January 12, 2024
From Benzinga
From Benzinga
Analyst Assesses Cell-Programming Focused Ginkgo Bioworks' Positioning Amid Revenue Surge, Program Adjustments
January 10, 2024
From Benzinga
Comparing Biogen With Industry Competitors In Biotechnology Industry
January 10, 2024
From Benzinga
Wall Street Thinks These 2 Biotech Stocks Could Soar in 2024
January 03, 2024
From Motley Fool
3 Biotech Stocks at the Forefront of the Quest for Eternal Youth
January 02, 2024
From InvestorPlace
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
From Benzinga
Healthcare Heroes: 3 Stocks Innovating in Medicine and Wellness
December 27, 2023
From InvestorPlace
From Benzinga
From Benzinga
Top 3 Healthcare Stock Picks for the New Year
December 25, 2023
From InvestorPlace
Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential
December 14, 2023
From InvestorPlace
Industry Comparison: Evaluating Biogen Against Competitors In Biotechnology Industry
December 13, 2023
Tickers
BIIB
From Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $7,200 Today
December 11, 2023
Tickers
BIIB
From Benzinga
2 Popular Stocks to Avoid Like the Plague in 2024 and Beyond
December 09, 2023
From Motley Fool
S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets
December 07, 2023
From Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
November 21, 2023
From Benzinga
Industry Comparison: Evaluating Biogen Against Competitors In Biotechnology Industry
November 14, 2023
Tickers
BIIB
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
